IgG4:IgG RNA ratio differentiates active disease from remission in granulomatosis with polyangiitis: a new disease activity marker? A cross-sectional and longitudinal study
Authors:
- A. Al-SoudiAAA. Al-Soudi
- M. E. DoorenspleetMDM. E. Doorenspleet
- R. E. EsveldtRER. E. Esveldt
- L. T. BurgemeisterLBL. T. Burgemeister
- A. E. HakAHA. E. Hak
- B. J. H. van Den BornBBB. J. H. van Den Born
- S. W. TasSTS. W. Tas
- R. F. van VollenhovenRVR. F. van Vollenhoven
- P. L. KlarenbeekPKP. L. Klarenbeek
- N. de VriesNVN. de Vries
Open Access
- 31 January 2019
- journal article
- research article
- Published by Springer Nature in Arthritis Research & Therapy
- Vol. 21 (1) , 1-11
Abstract
An important limitation in granulomatosis with polyangiitis (GPA) is the lack of disease activity markers. Immunoglobulin G4-positive (IgG4+) B cells and plasma cells are implicated in the pathogenesis of GPA. We hypothesized that the presence of these cells in peripheral blood could serve as disease activity parameter in GPA. We included 35 proteinase 3-antineutrophil cytoplasmic antibodies-positive patients with GPA in a cross-sectional study. Active disease was defined as Birmingham Vasculitis Activity Score (BVAS) ≥ 3 (n = 15), remission as BVAS of 0 (n = 17), and low disease activity (LDA) as BVAS of 1–2 and clinical remission (n = 3). Healthy subjects (n = 10), patients with systemic lupus erythematosus (n = 24), and patients with rheumatoid arthritis (n = 19) functioned as control subjects. An additional longitudinal study was performed in ten patients with GPA. Using a validated qPCR test, we measured the IgG4:IgG RNA ratio in all groups and compared the results with known biomarkers. The median qPCR score was higher in active GPA (21.4; IQR 12.1–29.6) than in remission/LDA (3.3; IQR 1.6–5.6) (Mann-Whitney U test, p < 0.0001) and outperformed other known disease activity parameters in detecting activity. A cutoff qPCR score of 11.2% differentiated active disease from remission/LDA accurately (AUC 0.993). The qPCR test correlated well with the BVAS (Spearman r = 0.77, p < 0.0001). In the longitudinal study, a decrease in BVAS correlated with qPCR score reduction (paired t test, p < 0.05). The IgG4:IgG RNA ratio in GPA accurately distinguishes active disease from remission and correlates well with disease activity in these single-center studies. If these results are confirmed in larger longitudinal studies, this test might help to steer treatment decisions in patients with GPA.Keywords
Funding Information
- ZonMw (436001001)
- Innovative Medicines Initiative (ABIRISK)
This publication has 43 references indexed in Scilit:
- Increased IgG4-Positive Plasma Cells in Granulomatosis with Polyangiitis: A Diagnostic Pitfall of IgG4-Related DiseaseInternational Journal of Rheumatology, 2012
- Muscle-specific kinase myasthenia gravis IgG4 autoantibodies cause severe neuromuscular junction dysfunction in miceBrain, 2012
- IgG4 immune response in Churg–Strauss syndromeAnnals of the Rheumatic Diseases, 2012
- Value of ANCA measurements during remission to predict a relapse of ANCA-associated vasculitis--a meta-analysisRheumatology, 2011
- Mechanism of Immunoglobulin G4 Fab-arm ExchangeJournal of the American Chemical Society, 2011
- Human T-cell memory consists mainly of unexpanded clonesImmunology Letters, 2010
- Prediction of relapses in PR3-ANCA-associated vasculitis by assessing responses of ANCA titres to treatmentRheumatology, 2006
- Limited versus severe Wegener's granulomatosis: Baseline data on patients in the Wegener's granulomatosis etanercept trialArthritis & Rheumatism, 2003
- IgG4 breaking the rulesImmunology, 2002
- Predominance of IgGl and IgG4 subclasses of anti-neutrophil cytoplasmic autoantibodies (ANCA) in patients with Wegener's granulomatosis and clinically related disordersClinical and Experimental Immunology, 1991